Around 4,500 women in the UK will be eligible for treatment with Gedeon Richter's once-daily oral therapy Ryeqo, after NICE backed the GnRH antagonist to treat heavy menstrual bleeding associated ...

IT’S something we don’t miss until it’s gone – our hearing. When we start to lose things with old age, including our eyesight ...

One study found that women who had received injectable progestins (i.e., usually Depo-Provera or norethisterone enanthate) for at least five years and who had used them at least five years prior ...

Around 1,000 women in England a year with endometriosis will soon have access to the first daily oral therapy after Gedeon Richter's Ryeqo was cleared for NHS use. This morning, NICE recommended ...

Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over TA1054 15 April 2025 15 April 2025 ...

Department of Systems Biology and Engineering, Silesian University of Technology, Akademicka 16, 44-100 Gliwice, Poland Biotechnology Center, Silesian University of Technology, B. Krzywoustego 8, ...

Older girls and women can be given hormone tablets of progesterone (norethisterone) to delay the onset of their periods. This has to be given every day starting three days before the predicted ...

Women gaining >5% of baseline weight at 3 months were at higher risk of more weight gain at 1 year No follow-up of discontinuers; lack of nonhormonal control group [23] ...

Third-generation oral contraceptives are an association of low-dose ethinyl estradiol and potent testosterone-derived progestins, developed in order to improve general and vascular tolerance. They ...